1. Home
  2. CERO vs BREA Comparison

CERO vs BREA Comparison

Compare CERO & BREA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CERO
  • BREA
  • Stock Information
  • Founded
  • CERO 2017
  • BREA 2022
  • Country
  • CERO United States
  • BREA Ireland
  • Employees
  • CERO N/A
  • BREA N/A
  • Industry
  • CERO
  • BREA Services-Misc. Amusement & Recreation
  • Sector
  • CERO
  • BREA Consumer Discretionary
  • Exchange
  • CERO Nasdaq
  • BREA Nasdaq
  • Market Cap
  • CERO 8.4M
  • BREA 8.7M
  • IPO Year
  • CERO N/A
  • BREA 2023
  • Fundamental
  • Price
  • CERO $2.06
  • BREA $0.63
  • Analyst Decision
  • CERO
  • BREA
  • Analyst Count
  • CERO 0
  • BREA 0
  • Target Price
  • CERO N/A
  • BREA N/A
  • AVG Volume (30 Days)
  • CERO 725.7K
  • BREA 40.6K
  • Earning Date
  • CERO 02-24-2025
  • BREA 01-03-2025
  • Dividend Yield
  • CERO N/A
  • BREA N/A
  • EPS Growth
  • CERO N/A
  • BREA N/A
  • EPS
  • CERO N/A
  • BREA N/A
  • Revenue
  • CERO N/A
  • BREA $2,872,101.00
  • Revenue This Year
  • CERO N/A
  • BREA N/A
  • Revenue Next Year
  • CERO N/A
  • BREA N/A
  • P/E Ratio
  • CERO N/A
  • BREA N/A
  • Revenue Growth
  • CERO N/A
  • BREA 2338.69
  • 52 Week Low
  • CERO $1.70
  • BREA $0.50
  • 52 Week High
  • CERO $1,095.00
  • BREA $2.44
  • Technical
  • Relative Strength Index (RSI)
  • CERO 37.15
  • BREA 38.35
  • Support Level
  • CERO $1.70
  • BREA $0.60
  • Resistance Level
  • CERO $2.22
  • BREA $0.67
  • Average True Range (ATR)
  • CERO 0.30
  • BREA 0.04
  • MACD
  • CERO 0.27
  • BREA -0.01
  • Stochastic Oscillator
  • CERO 24.32
  • BREA 13.91

About CERO CERo Therapeutics Holdings Inc. Common Stock

CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T-cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy.

About BREA Brera Holdings PLC

Brera Holdings PLC focused on expanding social impact football by developing a international portfolio of emerging football clubs with increased opportunities to earn tournament prizes, gain sponsorships, and provide other professional football and related consulting services.

Share on Social Networks: